Recruiting

Artificial Intelligence (AI)-Based Personalized Exercise Coaching for Patients With Breast Cancer

This prospective, single-center, randomized controlled trial aims to evaluate the effectiveness and safety of an artificial intelligence (AI)-based personalized exercise coaching system in female breast cancer survivors who have completed major cancer treatment and are clinically stable. A total of 100 eligible participants will be randomly assigned in a 1:1 ratio to either an AI-based exercise coaching group or a conventional exercise guidance group. Participants in the intervention group will receive…

I'm interested View official listing
ClinicalTrials.gov IDNCT07844941
PhaseNA
Enrollment60
SponsorShanghai Jiao Tong University School of Medicine
Age18 Years – 70 Years
SexFEMALE
I'm interested View official listing

Conditions studied

Breast Cancer

About this study

This prospective, single-center, randomized controlled trial aims to evaluate the effectiveness and safety of an artificial intelligence (AI)-based personalized exercise coaching system in female breast cancer survivors who have completed major cancer treatment and are clinically stable. A total of 100 eligible participants will be randomly assigned in a 1:1 ratio to either an AI-based exercise coaching group or a conventional exercise guidance group. Participants in the intervention group will receive personalized exercise recommendations generated by the AI exercise coaching system, with exercise data collected and used for dynamic adjustment of exercise guidance. Participants in the control group will receive conventional exercise recommendations provided by healthcare professionals. The intervention will last for 6 months. Exercise adherence will be evaluated as the primary outcome. Secondary outcomes will include quality of life, psychological status, physical function, exercise-related adverse events, and laboratory and metabolic parameters.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: 1. Provision of written and dated informed consent. 2. Female participants aged 18 to 70 years. 3. Pathologically confirmed breast malignancy. 4. Completion of major cancer treatment, including surgery, chemotherapy, and/or radiotherapy, with clinically stable disease. 5. No severe cardiopulmonary dysfunction or contraindications to exercise. Exclusion Criteria: 1. Have not undergone breast cancer surgery. 2. Mental or psychological condition, as judged by the investigator, that would prevent adherence to the intervention or completion of follow-up.

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-11-15.